TL;DR
- Appen's enterprise-facing segment, Appen Global, posted a 37% year-over-year revenue decline in Q1 FY26.
- Scale AI, TELUS Digital, iMerit, Sama, Labelbox, and TaskMonk each run a different delivery model.
- Managed-workforce vendors run delivery end to end. Platform-first tools need internal ops capacity.
- Quality control depth, not brand size, is what actually separates these vendors once you're in production.
- TaskMonk pairs a configurable QC platform with an optional managed workforce for teams that want both.
Appen's own earnings did something most vendor evaluations never get: they handed enterprise AI teams a hard number to point to. Appen Global, the segment that actually serves enterprise annotation programs rather than the company's China business, posted a 37% year-over-year revenue decline in Q1 FY26. Total company revenue still grew, which is exactly why the drop is easy to miss if you're only skimming the headline.
Searching "Appen alternatives" won't get you far on its own. That query is dominated by people looking for remote annotation gigs, not teams evaluating a vendor for a production pipeline. Strip that noise out and six vendors keep coming up in real enterprise shortlists: Scale AI, TELUS Digital, iMerit, Sama, Labelbox, and TaskMonk.
Each of them solves the problem differently: some hand you a platform and expect you to run it, some run the whole program for you, and a couple try to do both. Which one fits depends less on brand recognition and more on how you want quality control handled day to day. For a broader framework on that tradeoff, see this guide to choosing a data labeling platform.
Already know you want a platform plus managed workforce?
Get started right now
Why enterprise AI teams look for Appen alternatives
Two patterns show up whenever this conversation starts:
The first is workforce consistency. Appen leans on a large crowd-sourced pool, and independent reviews of crowd-sourced vendors flag the same trade-off every time: output quality swings with whoever picks up the task that day, not with what the vendor's process documentation promises.
The second is newer, and it's financial. A vendor can grow overall while the segment serving your program shrinks, which is exactly what Appen's own numbers show for its enterprise-facing business. Put those two together, workforce variance plus a contracting enterprise segment, and you get a wave of teams re-running vendor evaluations they hadn't touched in years.
None of that makes Appen unusable for every program. It does mean the six vendors below deserve a real bake-off instead of a quiet renewal. If you want the wider lens beyond just Appen's replacements, our breakdown of the best data labeling companies in 2026 covers how these six stack up against everyone else on modality, QC depth, and compliance.
Top Appen alternatives for enterprise teams
Scale AI: This is the vendor most teams already know from the headlines: Meta's multi-billion-dollar investment, an annualized revenue run rate reported above $750M, and a client list that reads like the frontier-lab leaderboard. Scale's consensus pipeline lets you collect multiple labeler responses per task and add adjudication stages when you need tighter agreement, which is the kind of control frontier RLHF programs actually require.
What it isn't built for is a mid-market team running a few thousand labels a month with smaller budgets. Pricing is entirely custom and sales-led, and independent procurement data puts average annual contracts around $93K, so the overhead only pays off at real scale.
TELUS Digital: TELUS International's 2021 acquisition of Lionbridge AI gave it telecom-grade infrastructure layered over an experienced annotation workforce spanning 300+ languages. That combination shows up most in content moderation and trust & safety datasets, where language coverage matters as much as annotation accuracy.
The tradeoff is scale: minimum engagement size and enterprise-only pricing make it a poor fit if your program is still small.
iMerit: iMerit made a deliberate bet against the crowd-sourcing model everyone else runs: full-time annotators instead of a rotating pool, with domain certifications for healthcare imaging and geospatial intelligence specifically. That specialization comes at a premium, and it's wasted if your annotation work is general-purpose classification rather than regulated, high-stakes data. Their recent acquisition by EXL might be something that you should read about.
If iMerit is already on your shortlist, our full comparison of iMerit alternatives goes deeper on where each option handles medical and geospatial work differently.
Sama: Sama built its name on an ethical sourcing model, full-time, trained annotators in underserved communities, paid under living-wage and benefits programs, rather than the fastest or cheapest crowd it could assemble. For teams that weigh workforce sourcing and long-run consistency as heavily as raw throughput, that model is the actual differentiator.
Teams optimizing purely for the lowest per-task cost will find better options elsewhere.
Labelbox: Labelbox holds a 4.5/5 rating on G2 from roughly 48 reviews, and the reviews consistently praise one thing: visibility into task, data, and labeler quality inside a governed platform. Model-assisted labeling and task-specific pre-labeling cut down manual work considerably.
What Labelbox doesn't do is run the program for you. It's platform-first, full stop, and G2 reviewers are candid about a real setup and customization learning curve if your team doesn't already have annotation ops experience in-house.
TaskMonk: TaskMonk sits in the middle of the spectrum most of these vendors occupy an extreme on. Instead of forcing a choice between a self-serve platform and a fully managed workforce, it gives you both under one contract: a QC platform built around Maker-Checker, Maker-Editor, and Majority Vote review, plus a managed workforce when you'd rather not staff the operation yourself. That combination fits teams migrating off a vendor whose bench is shrinking, since they get platform-level visibility into quality without hiring an internal ops team to run it.
More detail on how that QC actually works is below.
Comparison: Appen alternatives by delivery model
Pro tip: Ask every vendor on this list for unit economics by task and modality, not one blended rate. A blended number hides exactly which part of your program costs the most, which is the part you'd actually want to negotiate on.
Weighing TaskMonk against the rest of this list?
See TaskMonk's pricing and delivery options
How TaskMonk handles & what Appen doesn't
Appen's crowd-sourced model was built to move volume, not to give a program manager real-time visibility into quality. Two complaints come up again and again from teams evaluating a switch: output that wobbles whenever workforce demand shifts, and no way to see QC results until a batch is already delivered and it's too late to fix the run.
Maker-Checker, Maker-Editor, and Majority Vote: These aren't three names for the same review step. Maker-Checker is a straight approve-or-reject gate where the reviewer can't touch the label itself. Maker-Editor lets that same reviewer correct the label directly instead of just rejecting it and sending it back. Majority Vote routes a task to multiple annotators at once and accepts whatever a configured consensus percentage agrees on. Which method runs on which batch is a setting, not a fixed process, so a team can run tighter consensus on ambiguous edge cases and a lighter touch on the easy 80%.
Golden Data and Golden Accuracy: A Golden Batch is a set of tasks with known, correct answers, blended blindly into an annotator's normal queue at whatever ratio you configure. The annotator has no idea which tasks are golden. Their hit rate against that answer key becomes a Golden Accuracy score, which means quality gets measured continuously while work is happening, not reconstructed after the fact from a sample review.
Affinity-based routing: Predefined and Random Affinity route tasks by a specific field value, so a medical dataset lands with annotators who actually have medical labeling experience instead of whoever's next in the general queue. It sounds simple, but it's the difference between hoping domain expertise shows up and actually routing for it.
TaskMonk has processed 480M+ tasks, works with 10+ Fortune 500 teams, and holds a 4.6/5 rating on G2.
If your program is the one showing signs of vendor drift, book a demo with the TaskMonk team and run Maker-Checker or Majority Vote against your own edge cases. Not a sample dataset built to look clean.
Conclusion
The real cost of the wrong vendor rarely shows up as one bad batch. It shows up as a slow drift: quality that's fine on average but inconsistent at the edges, and a support relationship that gets thinner right as your program needs to scale. Teams that catch this early treat vendor evaluation as a standing check, not a decision made three years ago and never revisited.
Appen's numbers are just the current prompt to run that check. The same logic holds regardless of who you're using today. Between platform-first tools, managed-crowd vendors, managed full-time workforces, and hybrids like TaskMonk, the delivery model that fits your program almost certainly exists already. The work is matching QC depth and modality to the model, not defaulting to whichever name comes up first in a search.
Ready to test it on your own data?
Frequently Asked Questions
Who are Appen's competitors for enterprise data labeling?
For enterprise programs specifically, not gig work, the names that come up on real shortlists are Scale AI, TELUS Digital, iMerit, Sama, Labelbox, and TaskMonk. Which one counts as a true competitor depends on your modality and QC needs more than on category size. A team running frontier RLHF and a team running regulated medical imaging aren't actually choosing between the same two vendors.
What platforms are similar to Appen for AI teams, not gig work?
Scale AI and TELUS Digital are the closest match to Appen's own managed-crowd model, since both run large workforce pools rather than a small full-time team. If workforce consistency matters more to you than raw scale, iMerit and Sama run full-time annotators instead, trading some throughput ceiling for steadier quality.
Is Appen still a good fit for enterprise annotation programs in 2026?
It depends on what you're running. Appen still has scale, a long operating history, and a China business that's growing fast. But its enterprise-facing segment posted a sharp revenue decline in early 2026, and that's a real factor for any team weighing a multi-year commitment. If your program depends on steady, predictable delivery, that's exactly the risk worth pricing into the decision now rather than after the next earnings call.
.png)
